Skip to main content
Veterinary Medicines

INMUNAIR 17.5

Authorised
  • ESCHERICHIA COLI LIPOPOLYSACCHARIDE
  • Cutibacterium acnes, Inactivated

Product identification

Medicine name:
INMUNAIR 17.5
Active substance:
  • ESCHERICHIA COLI LIPOPOLYSACCHARIDE
  • Cutibacterium acnes, Inactivated
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • ESCHERICHIA COLI LIPOPOLYSACCHARIDE
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cutibacterium acnes, Inactivated
    0.17
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QL03AX
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 1403 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."